【艾昆纬】加速健康公平：挑战与机遇-2024.8_13页_3mb

Accelerating Health Equity: Challenges and Opportunities Summary

This report summarizes a roundtable discussion hosted by the IQVIA Institute for Human Data Science on April 18, 2024, focusing on challenges and opportunities in advancing health equity within the life sciences industry.

Key Report Highlights

• Introduction and Background: Achieving health equity is a priority across healthcare, especially in the life sciences sector. The industry has made commitments through declarations and established dedicated teams, but progress is complex and uncertain. The roundtable addressed three primary questions: successes in health equity, measuring impact and ROI, and overcoming challenges.

• Successes in Health Equity: Achievements stem from spotlight events like the COVID-19 pandemic and the murder of George Floyd, leading to increased focus on disparities in vulnerable populations. Success factors include dedicated DEI (diversity, equity, and inclusion) leadership, employee resource groups, and end-to-end efforts. However, challenges like internal fragmentation and lack of evidence persist, with backlash against DEI and ESG in some areas.

• Measuring Impact and ROI of Health Equity Investments:

  • Challenges include defining ill-served groups, metrics, and meaningful reach (e.g., social media impressions don't count).
  • Strategies involve collecting quantitative and qualitative data, using insights to demonstrate impact, and suggesting industry benchmarks similar to clinical trial diversity standards.
  • Observations highlight the need for clear definitions and collaborations to generate evidence of downstream effects.

• Greatest Challenges to Advancing Health Equity:

  • Internally: Business stakeholders may not fully grasp "the why" or see ROI, leading to hesitation in investments. Solutions include using data to make the case and establishing specific health equity metrics.
  • Externally: Backlash against DEI/ESG and limited evidence create barriers. Opportunities arise from sharing research methodologies and driving multi-stakeholder conversations through collaborations and standardized metrics.

• Commercial Opportunities: Engaging underserved communities builds product loyalty and health impact. Affirming the business case for health equity and global prioritization, including low- and middle-income countries, is emphasized.

Conclusion

Health equity must be embedded in business strategies for sustained impact. Future efforts include ongoing discussions and research to address gaps.

About the Institute

The IQVIA Institute for Human Data Science aims to advance human health through data-driven research and collaboration, with a focus on innovative solutions and ethical practices.